WHC is still in active development. Read this to understand our approach.
depiction of KQKPFRSPSRPDEB-UHFFFAOYSA-N.svg
isomerdesign

Sumatriptan

Check on isomerdesign

pubchem

Sumatriptan

Check on pubchem

drugmap

Sumatriptan

Check on drugmap

drugmap

Sumatriptan

Check on drugmap

wiki

Sumatriptan

Check on wiki

Data

InChI: InChI=1S/C14H21N3O2S/c1-15-20(18,19)10-11-4-5-14-13(8-11)12(9-16-14)6-7-17(2)3/h4-5,8-9,15-16H,6-7,10H2,1-3H3

Synonyms: SMR000596517,DTXSID4023628,3-(2-(Dimethylamino)ethyl)-N-methyl-1H-indole-5-methanesulfonamide,AB00698285_14,C90357,FT-0631027,BIDD:GT0248,103628-46-2,Q416978, 1-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]-N-methylmethanesulfonamide, Sumatriptanum [INN-Latin], Sumatriptanum,Tosymra (nasal spray),EN300-123008, 1-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}-N-methylmethanesulfonamide,AVP 825, Imitrex (TN),J-001014,Imigran,DFN-11 (SUMATRIPTAN INJECTION),SCHEMBL1482,Sumax,AVP-825,FT-0674779,3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole -5-methanesulphonamide,DSSTox_CID_3628, GR-43175,(3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide #, 3-[2-(Dimethylamino)ethyl]-N-methylindole-5-methanesulfonamide,CAS-103628-46-2,SUMATRIPTAN [MI],AB00698285_15,SUMATRIPTAN [WHO-DD],SUMATRIPTAN [ORANGE BOOK],N02CC01,3-[2-(Dimethylamino)ethyl]-N-methylindole-5-methanesulfonamide,UNII-8R78F6L9VO,DSSTox_RID_77118,Sumatriptan- Bio-X,SUMATRIPTAN [JAN],[3H]sumatriptan,AB00698285-13,GR 43175,SumatriptanSuccinate,1-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}-N-methylmethanesulfonamide, Sumatriptan (JAN/USP/INN),L000584,NCGC00095838-03, Sumax,SUMATRIPTAN [HSDB],ZINC14360,1-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]-N-methylmethanesulfonamide,Sumatriptanum [INN-Latin],1-(3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)-N-methylmethanesulfonamide,SUMATRIPTAN [USP MONOGRAPH],BS164424,1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methylmethanesulfonamide,1H-Indole-5-methanesulfonamide, 3-[2-(dimethylamino)ethyl]-N-methyl-, NP101, 3-[2-(Dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulfonamide,8R78F6L9VO,Sumatriptan,{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}-N-methylmethanesulfonamide,TOSYMRA,SUMATRIPTAN [VANDF],CCG-230331,C07319,SUMATRIPTAN [INN],Sumatran, GR 43175,3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulphonamide,SUMATRIPTAN [USP-RS],Sumatriptan [USP:INN:BAN],3-[2-(Dimethylamino)ethyl]-N-methy-1H-indole-5-methanesulfonamide,CHEMBL128, KS-1116,628S462,DB00669,Zecuity,GTPL54,HY-B0121B, GTPL119,MLS001195659,SPECTRUM1505372,AVP825,Imitrex (TN), 3-(2-(Dimethylamino)ethyl)-N-methyl-1H-indole-5-methanesulfonamide,(3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide,NCGC00095838-04,NCGC00095838-01,DFN-11,GR-43175,Sumatriptanum,STL451003,SBI-0206837.P001,HMS3369A05,1-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide,SUMATRIPTAN [MART.],3-[2-(Dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulfonamide, 1-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide,AMY17769,D00451, (3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide,1H-Indole-5-methanesulfonamide, 3-(2-(dimethylamino)ethyl)-N-methyl-,sumatriptan,NCGC00095838-02,1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide,HSDB 7742,Imitrex,BRN 6930870,AB00698285-12,CHEBI:10650,BSPBio_002304,CS-0009565, GR 43175X,Imigran Recovery,HMS2231B21,Imigran (TN),DSSTox_GSID_23628,Tox21_111528_1,Sumatriptan (JAN/USP/INN),AKOS015894924,Tox21_111528,BCP02237,BDBM50005835,GR 43175X,MLS001304742,BRD-K50938287-001-01-7, Imigran (TN)

Estimated data

Solubility: -2.54 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 30.6% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.